{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T15:27:24Z","timestamp":1791300444195,"version":"4.1.0"},"reference-count":238,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,6,17]],"date-time":"2020-06-17T00:00:00Z","timestamp":1592352000000},"content-version":"am","delay-in-days":352,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1016\/j.autrev.2019.05.006","type":"journal-article","created":{"date-parts":[[2019,5,3]],"date-time":"2019-05-03T20:58:55Z","timestamp":1556917135000},"page":"691-705","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":60,"title":["Myalgia and chronic fatigue syndrome following immunization: macrophagic myofasciitis and animal studies support linkage to aluminum adjuvant persistency and diffusion in the immune system"],"prefix":"10.1016","volume":"18","author":[{"given":"Romain K.","family":"Gherardi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillemette","family":"Cr\u00e9peaux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois-J\u00e9rome","family":"Authier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.autrev.2019.05.006_bb0005","author":"Launay"},{"key":"10.1016\/j.autrev.2019.05.006_bb0010","series-title":"Medicines in development for vaccines 2017 update","article-title":"America\u2019s biopharmaceutical research companies (PhRMA)","year":"2017"},{"key":"10.1016\/j.autrev.2019.05.006_bb0015","series-title":"Final report, February 7, 2018 Acts of Parliament, XVII legislature, Chamber of deputies, Doc XVII-bis N23","article-title":"Parliamentary commission of inquiry into cases of death and severe illnesses affecting military personnels\u2026","author":"Scanu","year":"2018"},{"issue":"2","key":"10.1016\/j.autrev.2019.05.006_bb0020","first-page":"162","article-title":"Lessons from macrophagic myofasciitis: towards definition of a vaccine adjuvant-related syndrome","volume":"159","author":"Gherardi","year":"2003","journal-title":"Rev Neurol (Paris)"},{"key":"10.1016\/j.autrev.2019.05.006_bb0025","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.jaut.2010.07.003","article-title":"'ASIA' - autoimmune\/inflammatory syndrome induced by adjuvants","volume":"36","author":"Shoenfeld","year":"2011","journal-title":"J Autoimmun"},{"issue":"17","key":"10.1016\/j.autrev.2019.05.006_bb0030","doi-asserted-by":"crossref","first-page":"2630","DOI":"10.2174\/092986711795933740","article-title":"Aluminum vaccine adjuvants: are they safe?","volume":"18","author":"Tomljenovic","year":"2011","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.autrev.2019.05.006_bb0035","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.jinorgbio.2017.12.015","article-title":"Critical analysis of reference studies on the toxicokinetics of aluminum-based adjuvants","volume":"181","author":"Masson","year":"2018","journal-title":"J Inorg Biochem"},{"key":"10.1016\/j.autrev.2019.05.006_bb0040","doi-asserted-by":"crossref","DOI":"10.1038\/srep31578","article-title":"Insight into the cellular fate and toxicity of aluminium adjuvants used in clinically approved human vaccinations","volume":"6","author":"Mold","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.autrev.2019.05.006_bb0045","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1038\/nri2510","article-title":"Towards an understanding of the adjuvant action of aluminium","volume":"9","author":"Marrack","year":"2009","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.autrev.2019.05.006_bb0050","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1093\/brain\/124.9.1821","article-title":"Macrophagic myofasciitis lesions assess long-term persistence of vaccine-derived aluminum hydroxide in muscle","volume":"124","author":"Gherardi","year":"2001","journal-title":"Brain"},{"key":"10.1016\/j.autrev.2019.05.006_bb0055","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1002\/art.10740","article-title":"Chronic fatigue syndrome in patients with macrophagic myofasciitis","volume":"48","author":"Authier","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2019.05.006_bb0060","doi-asserted-by":"crossref","first-page":"230","DOI":"10.3389\/fneur.2014.00230","article-title":"Clinical features in patients with long-lasting macrophagic myofasciitis","volume":"5","author":"Rigolet","year":"2014","journal-title":"Front Neurol"},{"issue":"1","key":"10.1016\/j.autrev.2019.05.006_bb0065","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s00296-014-3065-4","article-title":"Macrophagic myofasciitis and vaccination: consequence or coincidence?","volume":"35","author":"Santiago","year":"2015","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.autrev.2019.05.006_bb0070","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1093\/jnen\/nlx011","article-title":"Morin stain detects aluminum-containing macrophages in macrophagic myofasciitis and vaccination granuloma with high sensitivity and specificity","volume":"76","author":"Chkheidze","year":"2017","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1016\/j.autrev.2019.05.006_bb0075","series-title":"Board on the health of select populations, institute of medicine. Beyond myalgic encephalomyelitis\/chronic fatigue syndrome: redefining an illness","first-page":"10","author":"Institute of Medicine (US) Committee on the Diagnostic Criteria for Myalgic Encephalomyelitis\/Chronic Fatigue Syndrome","year":"2015"},{"key":"10.1016\/j.autrev.2019.05.006_bb0080","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1476-5918-7-6","article-title":"The economic impact of ME\/CFS: individual and societal costs","volume":"7","author":"Jason","year":"2008","journal-title":"Dyn Med"},{"issue":"7","key":"10.1016\/j.autrev.2019.05.006_bb0085","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0132421","article-title":"The health-related quality of life for patients with Myalgic Encephalomyelitis\/Chronic Fatigue Syndrome (ME\/CFS)","volume":"10","author":"Falk Hvidberg","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.autrev.2019.05.006_bb0090","doi-asserted-by":"crossref","first-page":"5929","DOI":"10.1002\/cncr.27612","article-title":"Chronic fatigue syndrome and subsequent risk of cancer among elderly US adults","volume":"118","author":"Chang","year":"2012","journal-title":"Cancer"},{"issue":"5","key":"10.1016\/j.autrev.2019.05.006_bb0095","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1007\/s10067-018-4009-2","article-title":"On chronic fatigue syndrome and nosological categories","volume":"37","author":"Sharif","year":"2018","journal-title":"Clin Rheumatol"},{"issue":"777","key":"10.1016\/j.autrev.2019.05.006_bb0100","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1136\/pgmj.66.777.526","article-title":"Myalgic encephalomyelitis\u2014a persistent enteroviral infection?","volume":"66","author":"Dowsett","year":"1990","journal-title":"Postgrad Med J"},{"issue":"2","key":"10.1016\/j.autrev.2019.05.006_bb0105","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1177\/014107689108400224","article-title":"A report-chronic fatigue syndrome: guidelines for research","volume":"84","author":"Sharpe","year":"1991","journal-title":"J R Soc Med"},{"issue":"12","key":"10.1016\/j.autrev.2019.05.006_bb0110","doi-asserted-by":"crossref","first-page":"953","DOI":"10.7326\/0003-4819-121-12-199412150-00009","article-title":"The chronic fatigue syndrome: a comprehensive approach to its definition and study. International chronic fatigue syndrome study group","volume":"121","author":"Fukuda","year":"1994","journal-title":"Ann Intern Med"},{"issue":"1","key":"10.1016\/j.autrev.2019.05.006_bb0115","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1300\/J092v11n01_02","article-title":"Myalgic encephalomyelitis\/chronic fatigue syndrome","volume":"11","author":"Carruthers","year":"2003","journal-title":"J Chron Fatigue Syndr"},{"key":"10.1016\/j.autrev.2019.05.006_bb0120","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1111\/j.1365-2796.2011.02428.x","article-title":"Myalgic encephalomyelitis: international consensus criteria","volume":"270","author":"Carruthers","year":"2011","journal-title":"J Intern Med"},{"issue":"2","key":"10.1016\/j.autrev.2019.05.006_bb0125","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2011-000252","article-title":"Unidentified Chronic Fatigue Syndrome\/myalgic encephalomyelitis (CFS\/ME) is a major cause of school absence: surveillance outcomes from school-based clinics","volume":"1","author":"Crawley","year":"2011","journal-title":"BMJ Open"},{"issue":"1","key":"10.1016\/j.autrev.2019.05.006_bb0130","first-page":"19","article-title":"Examining those Meeting IOM Criteria Versus IOM Plus Fibromyalgia","volume":"5","author":"Jason","year":"2017","journal-title":"Neurology (ECronicon)"},{"issue":"9","key":"10.1016\/j.autrev.2019.05.006_bb0135","doi-asserted-by":"crossref","first-page":"868","DOI":"10.7326\/0003-4819-134-9_Part_2-200105011-00011","article-title":"A review of the evidence for overlap among unexplained clinical conditions","volume":"134","author":"Aaron","year":"2001","journal-title":"Ann Intern Med"},{"issue":"2","key":"10.1016\/j.autrev.2019.05.006_bb0140","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1002\/art.1780330203","article-title":"The American College of Rheumatology 1990 criteria for the classification of fibromyalgia. Report of the multicenter criteria committee","volume":"33","author":"Wolfe","year":"1990","journal-title":"Arthritis Rheum"},{"issue":"3","key":"10.1016\/j.autrev.2019.05.006_bb0145","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.semarthrit.2016.08.012","article-title":"2016 Revisions to the 2010\/2011 fibromyalgia diagnostic criteria","volume":"46","author":"Wolfe","year":"2016","journal-title":"Semin Arthritis Rheum"},{"issue":"2","key":"10.1016\/j.autrev.2019.05.006_bb0150","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1002\/art.38905","article-title":"The prevalence of fibromyalgia in the general population: a comparison of the American College of Rheumatology 1990, 2010, and modified 2010 classification criteria","volume":"67","author":"Jones","year":"2015","journal-title":"Arthritis Rheumatol"},{"issue":"20","key":"10.1016\/j.autrev.2019.05.006_bb0155","doi-asserted-by":"crossref","first-page":"6024","DOI":"10.3748\/wjg.v20.i20.6024","article-title":"Irritable bowel syndrome: relations with functional, mental, and somatoform disorders","volume":"20","author":"Hausteiner-Wiehle","year":"2014","journal-title":"World J Gastroenterol"},{"issue":"10","key":"10.1016\/j.autrev.2019.05.006_bb0160","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1111\/j.1365-2982.2012.01993.x","article-title":"Overlap between functional GI disorders and other functional syndromes: what are the underlying mechanisms?","volume":"24","author":"Kim","year":"2012","journal-title":"Neurogastroenterol Motil"},{"issue":"1","key":"10.1016\/j.autrev.2019.05.006_bb0165","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1542\/peds.103.1.116","article-title":"Orthostatic intolerance in adolescent chronic fatigue syndrome","volume":"103","author":"Stewart","year":"1999","journal-title":"Pediatrics."},{"key":"10.1016\/j.autrev.2019.05.006_bb0170","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/S0165-1838(98)00177-5","article-title":"Orthostatic intolerance in the chronic fatigue syndrome","volume":"75","author":"Schondorf","year":"1999","journal-title":"J Auton Nerv Syst"},{"issue":"4","key":"10.1016\/j.autrev.2019.05.006_bb0175","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1042\/CS20110200","article-title":"Neurohumoral and haemodynamic profile in postural tachycardia and chronic fatigue syndromes","volume":"122","author":"Okamoto","year":"2012","journal-title":"Clin Sci (Lond)"},{"issue":"2","key":"10.1016\/j.autrev.2019.05.006_bb0180","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1177\/2049463714541423","article-title":"Establishing the characteristics for patients with chronic complex regional pain syndrome: the value of the CRPS-UK Registry","volume":"9","author":"Shenker","year":"2015","journal-title":"Br J Pain"},{"key":"10.1016\/j.autrev.2019.05.006_bb0185","doi-asserted-by":"crossref","first-page":"2550","DOI":"10.1007\/s12035-015-9262-7","article-title":"The putative role of viruses, bacteria, and chronic fungal biotoxin exposure in the genesis of intractable fatigue accompanied by cognitive and physical disability","volume":"53","author":"Morris","year":"2016","journal-title":"Mol Neurobiol"},{"issue":"6","key":"10.1016\/j.autrev.2019.05.006_bb0190","doi-asserted-by":"crossref","first-page":"E55","DOI":"10.3390\/jcm5060055","article-title":"A Role for the intestinal microbiota and virome in Myalgic Encephalomyelitis\/Chronic Fatigue Syndrome (ME\/CFS)?","volume":"5","author":"Navaneetharaja","year":"2016","journal-title":"J Clin Med"},{"issue":"2","key":"10.1016\/j.autrev.2019.05.006_bb0195","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1159\/000008144","article-title":"Chronic fatigue syndrome in patients with Lyme borreliosis","volume":"43","author":"Treib","year":"2000","journal-title":"Eur Neurol"},{"issue":"10","key":"10.1016\/j.autrev.2019.05.006_bb0200","first-page":"2263","article-title":"Rupture of silicone gel breast implants and symptoms of pain and fatigue","volume":"30","author":"Vermeulen","year":"2003","journal-title":"J Rheumatol"},{"issue":"4","key":"10.1016\/j.autrev.2019.05.006_bb0205","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/j.idc.2011.07.012","article-title":"The common immunogenic etiology of chronic fatigue syndrome: from infections to vaccines via adjuvants to the ASIA syndrome","volume":"25","author":"Rosenblum","year":"2011","journal-title":"Infect Dis Clin North Am"},{"key":"10.1016\/j.autrev.2019.05.006_bb0210","first-page":"753","article-title":"Metals as a common trigger of inflammation resulting in non-specific symptoms: diagnosis and treatment","volume":"16","author":"Stejskal","year":"2014","journal-title":"Isr Med Assoc J"},{"key":"10.1016\/j.autrev.2019.05.006_bb0215","series-title":"The clinical and scientific basis of myalgic encephalomyelitis\/chronic fatigue syndrome","author":"Hyde","year":"1992"},{"key":"10.1016\/j.autrev.2019.05.006_bb0220","first-page":"6","article-title":"Is CFS linked to vaccinations?","volume":"2","author":"Shepherd","year":"2001","journal-title":"The CFS Res Rev"},{"key":"10.1016\/j.autrev.2019.05.006_bb0225","first-page":"314","volume":"149","author":"Working group on the possible relationship between hepatitis B vaccination and the chronic fatigue syndrome","year":"1993","journal-title":"Rep Canad Med Assoc J"},{"issue":"1","key":"10.1016\/j.autrev.2019.05.006_bb0230","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.autrev.2008.07.026","article-title":"Chronic fatigue syndrome with autoantibodies\u2014the result of an augmented adjuvant effect of hepatitis-B vaccine and silicone implant","volume":"8","author":"Agmon-Levin","year":"2008","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2019.05.006_bb0235","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1007\/s12026-014-8604-2","article-title":"Chronic fatigue syndrome and fibromyalgia following immunization with the hepatitis B vaccine: another angle of the 'autoimmune (auto-inflammatory) syndrome induced by adjuvants' (ASIA)","volume":"60","author":"Agmon-Levin","year":"2014","journal-title":"Immunol Res"},{"key":"10.1016\/j.autrev.2019.05.006_bb0240","first-page":"4","article-title":"Biopersistence and brain translocation of aluminum adjuvants of vaccines","volume":"6","author":"Authier","year":"2015","journal-title":"Front Neurol"},{"key":"10.1016\/j.autrev.2019.05.006_bb0245","series-title":"Adverse effects of vaccines: evidence and causality","author":"Institute of Medicine","year":"2012"},{"key":"10.1016\/j.autrev.2019.05.006_bb0250","series-title":"Vaccine Safety Forum: Summaries of Two Workshops","author":"Institute of Medicine","year":"1997"},{"key":"10.1016\/j.autrev.2019.05.006_bb0255","author":"Joelving"},{"issue":"6","key":"10.1016\/j.autrev.2019.05.006_bb0260","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1177\/014107689108400612","article-title":"Spontaneous adverse drug reaction reporting vs event monitoring: a comparison","volume":"84","author":"Fletcher","year":"1991","journal-title":"J R Soc Med"},{"key":"10.1016\/j.autrev.2019.05.006_bb0265","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1093\/aje\/152.10.992","article-title":"Prevalence and patterns of Gulf War Illness in Kansas veterans: association of symptoms with characteristics of person, place, and time of military service","volume":"152","author":"Steele","year":"2000","journal-title":"Am J Epidemiol"},{"issue":"1","key":"10.1016\/j.autrev.2019.05.006_bb0270","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1289\/ehp.1003399","article-title":"Complex factors in the etiology of Gulf War illness: wartime exposures and risk factors in veteran subgroups","volume":"120","author":"Steele","year":"2012","journal-title":"Environ Health Perspect"},{"key":"10.1016\/j.autrev.2019.05.006_bb0275","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1001\/jama.280.11.981","article-title":"Chronic multisymptom illness affecting Air Force veterans of the Gulf War","volume":"280","author":"Fukuda","year":"1998","journal-title":"JAMA"},{"key":"10.1016\/j.autrev.2019.05.006_bb0280","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1046\/j.1365-2362.2000.00678.x","article-title":"Somatic hypotheses of war syndromes","volume":"30","author":"Soetekouw","year":"2000","journal-title":"Eur J Clin Invest"},{"issue":"7246","key":"10.1016\/j.autrev.2019.05.006_bb0285","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1136\/bmj.320.7246.1363","article-title":"Role of vaccinations as risk factors for ill health in veterans of the Gulf war: cross sectional study","volume":"320","author":"Hotopf","year":"2000","journal-title":"BMJ."},{"issue":"5","key":"10.1016\/j.autrev.2019.05.006_bb0290","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1136\/oem.58.5.299","article-title":"Health and exposures of United Kingdom Gulf war veterans. Part II: The relation of health to exposure","volume":"58","author":"Cherry","year":"2001","journal-title":"Occup Environ Med"},{"issue":"9148","key":"10.1016\/j.autrev.2019.05.006_bb0295","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0140-6736(98)11338-7","article-title":"Health of UK servicemen who served in Persian Gulf War","volume":"353","author":"Unwin","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.autrev.2019.05.006_bb0300","series-title":"Health study of Canadian forces personnel involved in the 1991 conflict in the Persian Gulf","volume":"vol. 1","author":"Gilroy, G., Inc.","year":"1998"},{"issue":"2","key":"10.1016\/j.autrev.2019.05.006_bb0305","doi-asserted-by":"crossref","first-page":"639","DOI":"10.2466\/pr0.2002.90.2.639","article-title":"Self-reported changes in subjective health and anthrax vaccination as reported by over 900 Persian Gulf War era veterans","volume":"90","author":"Schumm","year":"2002","journal-title":"Psychol Rep"},{"issue":"5","key":"10.1016\/j.autrev.2019.05.006_bb0310","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1007\/s10067-007-0793-9","article-title":"Polyglandular autoimmunity with macrophagic myofasciitis 1","volume":"27","author":"Theeler","year":"2008","journal-title":"Clin Rheumatol"},{"issue":"1","key":"10.1016\/j.autrev.2019.05.006_bb0315","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1006\/exmp.2002.2429","article-title":"Antibodies to squalene in recipients of anthrax vaccine","volume":"73","author":"Asa","year":"2002","journal-title":"Exp Mol Pathol"},{"issue":"29","key":"10.1016\/j.autrev.2019.05.006_bb0320","doi-asserted-by":"crossref","first-page":"3921","DOI":"10.1016\/j.vaccine.2009.03.091","article-title":"Antibodies to squalene in US Navy Persian Gulf War veterans with chronic multisymptom illness","volume":"27","author":"Phillips","year":"2009","journal-title":"Vaccine"},{"issue":"9125","key":"10.1016\/j.autrev.2019.05.006_bb0325","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/S0140-6736(98)02326-5","article-title":"Macrophagic myofasciitis: an emerging entity","volume":"352","author":"Gherardi","year":"1998","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.autrev.2019.05.006_bb0330","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1111\/nan.12231","article-title":"Th2-M2 immunity in lesions of muscular sarcoidosis and macrophagic myofasciitis","volume":"41","author":"Preusse","year":"2015","journal-title":"Neuropathol Appl Neurobiol"},{"issue":"4","key":"10.1016\/j.autrev.2019.05.006_bb0335","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/S0889-8561(03)00095-X","article-title":"Aluminum inclusion macrophagic myofasciitis: a recently identified condition","volume":"23","author":"Gherardi","year":"2003","journal-title":"Immunol Allergy Clin North Am"},{"issue":"11","key":"10.1016\/j.autrev.2019.05.006_bb0340","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1136\/ard.59.11.926b","article-title":"Familial macrophagic myofasciitis","volume":"59","author":"Amoura","year":"2000","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"10.1016\/j.autrev.2019.05.006_bb0345","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1002\/art.10666","article-title":"Identical twins with macrophagic myofasciitis: genetic susceptibility and triggering by aluminic vaccine adjuvants?","volume":"47","author":"Guis","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2019.05.006_bb0350","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.biopha.2004.04.012","article-title":"Blood oxidative stress status in patients with macrophagic myofasciitis","volume":"58","author":"Bonnefont-Rousselot","year":"2004","journal-title":"Biomed Pharmacother"},{"issue":"3","key":"10.1016\/j.autrev.2019.05.006_bb0355","doi-asserted-by":"crossref","first-page":"145","DOI":"10.5694\/j.1326-5377.2005.tb06963.x","article-title":"Macrophagic myofasciitis associated with vaccine-derived aluminium","volume":"183","author":"Shingde","year":"2005","journal-title":"Med J Aust"},{"issue":"1","key":"10.1016\/j.autrev.2019.05.006_bb0360","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1080\/01913120601169550","article-title":"Macrophagic myofasciitis in childhood: the role of scanning electron microscopy\/energy-dispersive spectroscopy for diagnosis","volume":"31","author":"Kalil","year":"2007","journal-title":"Ultrastruct Pathol"},{"issue":"1","key":"10.1016\/j.autrev.2019.05.006_bb0365","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1111\/j.1750-3639.2004.tb00504.x","article-title":"July 2003: 62-year-old female with progressive muscular weakness","volume":"14","author":"Bornemann","year":"2004","journal-title":"Brain Pathol"},{"issue":"4","key":"10.1016\/j.autrev.2019.05.006_bb0370","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1055\/s-0035-1557224","article-title":"Macrophagic myofasciitis in a 3-month-old child","volume":"vol. 2","author":"Sharma","year":"2004","journal-title":"J Pediatr Neurol"},{"issue":"4","key":"10.1016\/j.autrev.2019.05.006_bb0375","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1055\/s-0029-1243172","article-title":"Macrophagic myofasciitis plus (distinct types of muscular dystrophy)","volume":"40","author":"Muller","year":"2009","journal-title":"Neuropediatrics"},{"issue":"14","key":"10.1016\/j.autrev.2019.05.006_bb0380","first-page":"248","volume":"106","author":"Stenzel","year":"2009","journal-title":"Dtsch Arztebl Int"},{"issue":"1","key":"10.1016\/j.autrev.2019.05.006_bb0385","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1002\/mus.25467","article-title":"Childhood macrophagic myofasciitis: A series from the Indian subcontinent","volume":"56","author":"Kakkar","year":"2017","journal-title":"Muscle Nerve"},{"issue":"12","key":"10.1016\/j.autrev.2019.05.006_bb0390","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/j.nmd.2006.07.017","article-title":"Atypical presentation of macrophagic myofasciitis 10 years post vaccination","volume":"16","author":"Ryan","year":"2006","journal-title":"Neuromuscul Disord"},{"issue":"4","key":"10.1016\/j.autrev.2019.05.006_bb0395","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.nmd.2003.12.005","article-title":"Childhood macrophagic myofasciitis-consanguinity and clinicopathological features","volume":"14","author":"Nevo","year":"2004","journal-title":"Neuromuscul Disord"},{"issue":"2","key":"10.1016\/j.autrev.2019.05.006_bb0400","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.nmd.2003.09.007","article-title":"Macrophagic myofasciitis: an infantile Italian case","volume":"14","author":"Di Muzio","year":"2004","journal-title":"Neuromuscul Disord"},{"issue":"1","key":"10.1016\/j.autrev.2019.05.006_bb0405","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s11739-014-1138-8","article-title":"A young man with persistent myalgia and fatigue: an off-label therapeutic approach","volume":"10","author":"Russo","year":"2015","journal-title":"Intern Emerg Med"},{"issue":"1","key":"10.1016\/j.autrev.2019.05.006_bb0410","first-page":"75","article-title":"Macrophagic myofasciitis: a case report of autoimmune\/ inflammatory syndrome induced by adjuvants (ASIA)","volume":"36","author":"Polido Pereira","year":"2011","journal-title":"Acta Reumatol Port"},{"key":"10.1016\/j.autrev.2019.05.006_bb0415","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2018-224602","article-title":"Macrophagic myofasciitis: a challenging diagnosis","author":"Soares Santos","year":"2018","journal-title":"BMJ Case Rep"},{"issue":"6","key":"10.1016\/j.autrev.2019.05.006_bb0420","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1177\/0883073807312370","article-title":"Macrophagic myofasciitis in children is a localized reaction to vaccination","volume":"23","author":"Lach","year":"2008","journal-title":"J Child Neurol"},{"issue":"5","key":"10.1016\/j.autrev.2019.05.006_bb0425","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.pediatrneurol.2005.05.024","article-title":"Macrophagic myofasciitis in childhood: a controversial entity","volume":"33","author":"Rivas","year":"2005","journal-title":"Pediatr Neurol"},{"issue":"2","key":"10.1016\/j.autrev.2019.05.006_bb0430","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.mehy.2008.09.040","article-title":"A role for the body burden of aluminium in vaccine-associated macrophagic myofasciitis and chronic fatigue syndrome 1","volume":"72","author":"Exley","year":"2009","journal-title":"Med Hypotheses"},{"issue":"7","key":"10.1016\/j.autrev.2019.05.006_bb0435","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1111\/j.1365-2990.2012.01293.x","article-title":"Macrophagic myofasciitis: a report of second case from UK","volume":"38","author":"Shivane","year":"2012","journal-title":"Neuropathol Appl Neurobiol"},{"issue":"2","key":"10.1016\/j.autrev.2019.05.006_bb0440","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s10024001-0137-8","article-title":"Aluminum phagocytosis in quadriceps muscle following vaccination in children: relationship to macrophagic myofasciitis","volume":"5","author":"Lacson","year":"2002","journal-title":"Pediatr Dev Pathol"},{"issue":"4","key":"10.1016\/j.autrev.2019.05.006_bb0445","first-page":"172","article-title":"Pediatric macrophagic myofasciitis associated with motor delay","volume":"25","author":"Gruis","year":"2006","journal-title":"Clin Neuropathol"},{"key":"10.1016\/j.autrev.2019.05.006_bb0450","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1016\/j.vaccine.2004.09.012","article-title":"Aluminium assay and evaluation of the local reaction at several time points after intramuscular administration of aluminium containing vaccines in the cynomolgus monkey","volume":"23","author":"Verdier","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.autrev.2019.05.006_bb0455","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.nmd.2006.02.004","article-title":"AlOH3-adjuvanted vaccine-induced macrophagic myofasciitis in rats is influenced by the genetic background","volume":"16","author":"Authier","year":"2006","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.autrev.2019.05.006_bb0460","article-title":"Granulomas Following Subcutaneous Injection With Aluminum Adjuvant-Containing Products in Sheep","author":"As\u00edn","year":"2018","journal-title":"Vet Pathol"},{"key":"10.1016\/j.autrev.2019.05.006_bb0465","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1177\/096032719501400309","article-title":"Human metabolism of aluminium-26 and gallium-67 injected as citrates","volume":"14","author":"Priest","year":"1995","journal-title":"Hum Exp Toxicol"},{"key":"10.1016\/j.autrev.2019.05.006_bb0470","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1016\/S0264-410X(97)00041-8","article-title":"In vivo absorption of aluminium containing vaccine adjuvants using 26 Al","volume":"15","author":"Flarend","year":"1997","journal-title":"Vaccine"},{"key":"10.1016\/j.autrev.2019.05.006_bb0475","doi-asserted-by":"crossref","first-page":"9538","DOI":"10.1016\/j.vaccine.2011.09.124","article-title":"Updated aluminum pharmacokinetics following infant exposures through diet and vaccination","volume":"29","author":"Mitkus","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.autrev.2019.05.006_bb0480","first-page":"338","article-title":"Macrophagic myofasciitis and aluminum-containing vaccines","volume":"74","author":"World Health Organization Vaccine Safety Advisory Committee","year":"1999","journal-title":"Wkly Epidemiol Rec"},{"issue":"7","key":"10.1016\/j.autrev.2019.05.006_bb0485","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1177\/096032719501400707","article-title":"Inter-subject variability in the metabolism of aluminium following intravenous injection as citrate","volume":"14","author":"Talbot","year":"1995","journal-title":"Hum Exp Toxicol"},{"issue":"9","key":"10.1016\/j.autrev.2019.05.006_bb0490","doi-asserted-by":"crossref","first-page":"2535","DOI":"10.1002\/art.10465","article-title":"HLA-DRB1*01 and macrophagic myofasciitis","volume":"46","author":"Guis","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2019.05.006_bb0495","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/1741-7015-11-99","article-title":"Slow CCL2-dependent translocation of biopersistent particles from muscle to brain","volume":"11","author":"Khan","year":"2013","journal-title":"BMC Med"},{"issue":"4","key":"10.1016\/j.autrev.2019.05.006_bb0500","doi-asserted-by":"crossref","first-page":"511","DOI":"10.2174\/09298673113206660287","article-title":"Selective elevation of circulating CCL2\/MCP1 levels in patients with longstanding post-vaccinal macrophagic myofasciitis and ASIA","volume":"21","author":"Cadusseau","year":"2014","journal-title":"Curr Med Chem"},{"issue":"1","key":"10.1016\/j.autrev.2019.05.006_bb0505","first-page":"37","article-title":"Biopersistence and systemic distribution of intramuscularly injected particles: what impact on long-term tolerability of alum adjuvants?","volume":"198","author":"Gherardi","year":"2014","journal-title":"Bull Acad Natl Med"},{"key":"10.1016\/j.autrev.2019.05.006_bb0510","doi-asserted-by":"crossref","first-page":"7052","DOI":"10.1039\/c4nr01234h","article-title":"A general mechanism for intracellular toxicity of metal-containing nanoparticles","volume":"6","author":"Sabella","year":"2014","journal-title":"Nanoscale"},{"issue":"11","key":"10.1016\/j.autrev.2019.05.006_bb0515","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1021\/tx500264s","article-title":"Toxic Metals and Autophagy","volume":"27","author":"Chatterjee","year":"2014","journal-title":"Chem Res Toxicol"},{"issue":"4","key":"10.1016\/j.autrev.2019.05.006_bb0520","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/S0889-8561(03)00095-X","article-title":"Aluminum inclusion macrophagic myofasciitis: a recently identified condition","volume":"23","author":"Gherardi","year":"2003","journal-title":"Immunol Allergy Clin North Am"},{"key":"10.1016\/j.autrev.2019.05.006_bb0525","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.jinorgbio.2013.07.020","article-title":"Distinctive clinical features in arthro-myalgic patients with and without aluminum hydroxyde-induced macrophagic myofasciitis: an exploratory study","volume":"128","author":"Ragunathan-Thangarajah","year":"2013","journal-title":"J Inorg Biochem"},{"issue":"11","key":"10.1016\/j.autrev.2019.05.006_bb0530","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1016\/j.jinorgbio.2009.08.005","article-title":"Long-term persistence of vaccine-derived aluminum hydroxide is associated with chronic cognitive dysfunction","volume":"103","author":"Couette","year":"2009","journal-title":"J Inorg Biochem"},{"issue":"11","key":"10.1016\/j.autrev.2019.05.006_bb0535","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1016\/j.jinorgbio.2011.08.006","article-title":"Long-term follow-up of cognitive dysfunction in patients with aluminum hydroxide-induced macrophagic myofasciitis (MMF)","volume":"105","author":"Passeri","year":"2011","journal-title":"J Inorg Biochem"},{"key":"10.1016\/j.autrev.2019.05.006_bb0540","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.jinorgbio.2017.09.019","article-title":"Cognitive dysfunction associated with aluminum hydroxide-induced macrophagic myofasciitis: A reappraisal of neuropsychological profile","volume":"181","author":"Aoun Sebaiti","year":"2018","journal-title":"J Inorg Biochem"},{"issue":"6","key":"10.1016\/j.autrev.2019.05.006_bb0545","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0128353","article-title":"Neuropsychological Correlates of Brain Perfusion SPECT in Patients with Macrophagic Myofasciitis","volume":"10","author":"Van Der Gucht","year":"2015","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.autrev.2019.05.006_bb0550","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1007\/s13139-015-0371-z","article-title":"FDG-PET\/CT Brain Findings in a Patient With Macrophagic Myofasciitis","volume":"50","author":"Van Der Gucht","year":"2016","journal-title":"Nucl Med Mol Imaging"},{"issue":"3","key":"10.1016\/j.autrev.2019.05.006_bb0555","doi-asserted-by":"crossref","first-page":"492","DOI":"10.2967\/jnumed.114.151878","article-title":"Brain (18)F-FDG PET Metabolic Abnormalities in Patients with Long-Lasting Macrophagic Myofascitis","volume":"58","author":"Van Der Gucht","year":"2017","journal-title":"J Nucl Med"},{"issue":"39","key":"10.1016\/j.autrev.2019.05.006_bb0560","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000008134","article-title":"Predictive value of brain 18F-FDG PET\/CT in macrophagic myofasciitis?: A case report","volume":"96","author":"Van Der Gucht","year":"2017","journal-title":"Medicine (Baltimore)"},{"issue":"7","key":"10.1016\/j.autrev.2019.05.006_bb0565","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0181152","article-title":"Cerebral 18F-FDG PET in macrophagic myofasciitis: An individual SVM-based approach","volume":"12","author":"Blanc-Durand","year":"2017","journal-title":"PLoS One"},{"issue":"9","key":"10.1016\/j.autrev.2019.05.006_bb0570","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.2967\/jnumed.117.190876","article-title":"Brain (18)F-FDG PET Metabolic Abnormalities in Macrophagic Myofasciitis: Are They Stable?","volume":"58","author":"Blanc-Durand","year":"2017","journal-title":"J Nucl Med"},{"key":"10.1016\/j.autrev.2019.05.006_bb0575","author":"Agence Nationale de S\u00e9curit\u00e9 du M\u00e9dicament"},{"key":"10.1016\/j.autrev.2019.05.006_bb0580","author":"Cazeneuve"},{"issue":"10","key":"10.1016\/j.autrev.2019.05.006_bb0585","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1136\/archdischild-2011-301307","article-title":"Complex regional pain syndrome following immunisation","volume":"97","author":"Richards","year":"2012","journal-title":"Arch Dis Child"},{"issue":"6","key":"10.1016\/j.autrev.2019.05.006_bb0590","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1067\/S0022-3476(03)00536-5","article-title":"Complex regional pain syndrome after hepatitis B vaccine","volume":"143","author":"Jastaniah","year":"2003","journal-title":"J Pediatr"},{"key":"10.1016\/j.autrev.2019.05.006_bb0595","doi-asserted-by":"crossref","first-page":"3","DOI":"10.15406\/ijvv.2015.01.00003","article-title":"Is Chronic fatigue syndrome\/Myalgic encephalomyelitis a relevant diagnosis in patients with suspected side effects to Human papilloma virus vaccine?","volume":"1","author":"Brinth","year":"2015","journal-title":"Int J Vaccines Vaccin"},{"issue":"22","key":"10.1016\/j.autrev.2019.05.006_bb0600","doi-asserted-by":"crossref","first-page":"2602","DOI":"10.1016\/j.vaccine.2015.03.098","article-title":"Orthostatic intolerance and postural tachycardia syndrome as suspected adverse effects of vaccination against human papilloma virus","volume":"33","author":"Brinth","year":"2015","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.autrev.2019.05.006_bb0605","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1007\/s12026-016-8820-z","article-title":"Severe somatoform and dysautonomic syndromes after HPV vaccination: case series and review of literature","volume":"65","author":"Palmieri","year":"2017","journal-title":"Immunol Res"},{"issue":"1","key":"10.1016\/j.autrev.2019.05.006_bb0610","article-title":"Postural orthostatic tachycardia with chronic fatigue after HPV vaccination as part of the \"autoimmune\/auto-inflammatory syndrome induced by adjuvants\": case report and literature review","volume":"2","author":"Tomljenovic","year":"2014","journal-title":"J Investig Med High Impact Case Rep"},{"key":"10.1016\/j.autrev.2019.05.006_bb0615","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.2169\/internalmedicine.53.3133","article-title":"Peripheral sympathetic nerve dysfunction in adolescent Japanese girls following immunization with the human papillomavirus vaccine","volume":"53","author":"Kinoshita","year":"2014","journal-title":"Intern Med"},{"issue":"1","key":"10.1016\/j.autrev.2019.05.006_bb0620","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1007\/s12026-016-8859-x","article-title":"Involvement of chronic epipharyngitis in autoimmune (auto-inflammatory) syndrome induced by adjuvants (ASIA)","volume":"65","author":"Hotta","year":"2017","journal-title":"Immunol Res"},{"key":"10.1016\/j.autrev.2019.05.006_bb0625","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1007\/s40264-017-0574-6","article-title":"Suspected adverse effects after Human Papillomavirus vaccination: a temporal relationship between vaccine administration and the appearance of symptoms in Japan","volume":"40","author":"Ozawa","year":"2017","journal-title":"Drug Saf"},{"key":"10.1016\/j.autrev.2019.05.006_bb0630","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1007\/s10067-015-3070-3","article-title":"HPV vaccination syndrome. A questionnaire-based study","volume":"34","author":"Mart\u00ednez-Lav\u00edn","year":"2015","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.autrev.2019.05.006_bb0635","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1111\/ene.12272","article-title":"Postural tachycardia syndrome following human papillomavirus vaccination","volume":"21","author":"Blitshteyn","year":"2014","journal-title":"Eur J Neurol"},{"issue":"5","key":"10.1016\/j.autrev.2019.05.006_bb0640","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1212\/01.WNL.0000138433.61870.82","article-title":"Recombinant hepatitis B vaccine and the risk of multiple sclerosis: a prospective study","volume":"63","author":"Hern\u00e1n","year":"2004","journal-title":"Neurology"},{"issue":"2\u20133","key":"10.1016\/j.autrev.2019.05.006_bb0645","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/s12026-014-8574-4","article-title":"Evolution of multiple sclerosis in France since the beginning of hepatitis B vaccination","volume":"60","author":"Le Hou\u00e9zec","year":"2014","journal-title":"Immunol Res"},{"key":"10.1016\/j.autrev.2019.05.006_bb0650","article-title":"Central demyelinating diseases after vaccination against Hepatitis B Virus: A disproportionality analysis within the VAERS database","author":"Mouchet","year":"2018","journal-title":"Drug Saf"},{"issue":"5","key":"10.1016\/j.autrev.2019.05.006_bb0655","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1093\/brain\/124.5.974","article-title":"Central nervous system disease in patients with macrophagic myofasciitis","volume":"124","author":"Authier","year":"2001","journal-title":"Brain"},{"issue":"4","key":"10.1016\/j.autrev.2019.05.006_bb0660","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s40264-017-0625-z","article-title":"Safety of human papillomavirus vaccines: an updated review","volume":"41","author":"Phillips","year":"2018","journal-title":"Drug Saf"},{"key":"10.1016\/j.autrev.2019.05.006_bb0665","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.anpedi.2013.11.031","article-title":"Adverse reactions to human papillomavirus vaccine in the Valencian Community (2007\u20132011)","volume":"81","author":"Rodr\u00edguez-Gal\u00e1n","year":"2014","journal-title":"An Pediatr (Barc)"},{"key":"10.1016\/j.autrev.2019.05.006_bb0670","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1016\/j.vaccine.2016.02.040","article-title":"Adverse events following HPV vaccination, Alberta 2006-2014","volume":"34","author":"Liu","year":"2016","journal-title":"Vaccine"},{"issue":"43","key":"10.1016\/j.autrev.2019.05.006_bb0675","doi-asserted-by":"crossref","first-page":"5753","DOI":"10.1016\/j.vaccine.2017.05.069","article-title":"Human papillomavirus vaccines: WHO position paper, May 2017-Recommendations","volume":"35","author":"WHO","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.autrev.2019.05.006_bb0680","author":"European Medicines"},{"issue":"5","key":"10.1016\/j.autrev.2019.05.006_bb0685","article-title":"Prophylactic vaccination against human papillomaviruses to prevent cervical cancer and its precursors","author":"Arbyn","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.autrev.2019.05.006_bb0690","first-page":"41","article-title":"Cochrane review on HPV vaccine should be revised due to missing trials, adjuvant toxicity, mortality and healthy user bias in observational studies","volume":"4","author":"Hama","year":"2018","journal-title":"Med Check-TIP"},{"key":"10.1016\/j.autrev.2019.05.006_bb0695","author":"G\u00f8tzsche"},{"issue":"10","key":"10.1016\/j.autrev.2019.05.006_bb0700","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1007\/s10067-017-3768-5","article-title":"Serious adverse events after HPV vaccination: a critical review of randomized trials and post-marketing case series","volume":"36","author":"Mart\u00ednez-Lav\u00edn","year":"2017","journal-title":"Clin Rheumatol"},{"issue":"5","key":"10.1016\/j.autrev.2019.05.006_bb0705","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1007\/s40264-018-0657-z","article-title":"Comment on \"safety of human papillomavirus vaccines: an updated review\"","volume":"41","author":"Chandler","year":"2018","journal-title":"Drug Saf"},{"key":"10.1016\/j.autrev.2019.05.006_bb0710","article-title":"Human papillomavirus vaccines, complex regional pain syndrome, postural orthostatic tachycardia syndrome, and autonomic dysfunction \u2013 a review of the regulatory evidence from the European medicines agency","volume":"006","author":"Jefferson","year":"2017","journal-title":"Indian J Med Ethics"},{"issue":"5","key":"10.1016\/j.autrev.2019.05.006_bb0715","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1136\/bmjebm-2018-111012","article-title":"The Cochrane HPV vaccine review was incomplete and ignored important evidence of bias","volume":"23","author":"J\u00f8rgensen","year":"2018","journal-title":"BMJ Evid Based Med"},{"issue":"43","key":"10.1016\/j.autrev.2019.05.006_bb0720","doi-asserted-by":"crossref","first-page":"4961","DOI":"10.1016\/j.vaccine.2013.08.024","article-title":"Bivalent human papillomavirus vaccine and the risk of fatigue syndromes in girls in the UK","volume":"31","author":"Donegan","year":"2013","journal-title":"Vaccine."},{"issue":"33","key":"10.1016\/j.autrev.2019.05.006_bb0725","doi-asserted-by":"crossref","first-page":"4203","DOI":"10.1016\/j.vaccine.2017.06.031","article-title":"HPV vaccination and risk of chronic fatigue syndrome\/myalgic encephalomyelitis: a nationwide register-based study from Norway","volume":"35","author":"Feiring","year":"2017","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.autrev.2019.05.006_bb0730","doi-asserted-by":"crossref","first-page":"385","DOI":"10.2165\/00002018-200629050-00003","article-title":"Under-reporting of adverse drug reactions : a systematic review","volume":"29","author":"Hazell","year":"2006","journal-title":"Drug Saf"},{"issue":"2","key":"10.1016\/j.autrev.2019.05.006_bb0735","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.arcped.2005.10.020","article-title":"Pharmacovigilance of vaccines","volume":"13","author":"Autret-Leca","year":"2006","journal-title":"Arch Pediatr"},{"key":"10.1016\/j.autrev.2019.05.006_bb0740","first-page":"49","article-title":"Adverse effects of human papilloma virus vaccination on central nervous system","volume":"53","author":"Hirai","year":"2016","journal-title":"Auton Nerv Syst"},{"key":"10.1016\/j.autrev.2019.05.006_bb0745","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1093\/oxfordjournals.aje.a116479","article-title":"Confounding in studies of adverse reactions to vaccines","volume":"136","author":"Fine","year":"1992","journal-title":"Am J Epidemiol"},{"issue":"4","key":"10.1016\/j.autrev.2019.05.006_bb0750","doi-asserted-by":"crossref","first-page":"139","DOI":"10.4161\/hv.3.4.4309","article-title":"Effect of alternative aluminum adjuvants on the absorption and immunogenicity of HPV16 L1 VLPs in mice","volume":"3","author":"Caulfield","year":"2007","journal-title":"Hum Vaccin"},{"issue":"12","key":"10.1016\/j.autrev.2019.05.006_bb0755","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1007\/s40264-017-0593-3","article-title":"Safety Concerns with HPV vaccines continue to linger: are current vaccine pharmacovigilance practices sufficient?","volume":"40","author":"Chandler","year":"2017","journal-title":"Drug Saf"},{"key":"10.1016\/j.autrev.2019.05.006_bb0760","author":"Yang"},{"key":"10.1016\/j.autrev.2019.05.006_bb0765","author":"College of physicians of Philadelphia"},{"issue":"144","key":"10.1016\/j.autrev.2019.05.006_bb0770","article-title":"Fluorescent nanodiamonds as a relevant tag for the assessment of alum adjuvant particle biodisposition","volume":"13","author":"Eidi","year":"2015","journal-title":"BMC Med"},{"key":"10.1016\/j.autrev.2019.05.006_bb0775","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.jinorgbio.2015.07.004","article-title":"Highly delayed systemic translocation of aluminum-based adjuvant in CD1 mice following intramuscular injections","volume":"152","author":"Cr\u00e9peaux","year":"2015","journal-title":"J Inorg Biochem"},{"key":"10.1016\/j.autrev.2019.05.006_bb0780","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1096\/fj.11-184556","article-title":"Antigen depot is not required for alum adjuvanticity","volume":"26","author":"Hutchison","year":"2012","journal-title":"FASEB J"},{"key":"10.1016\/j.autrev.2019.05.006_bb0785","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.it.2009.12.009","article-title":"The immunobiology of aluminium adjuvants: how do they really work?","volume":"31","author":"Exley","year":"2010","journal-title":"Trends Immunol"},{"key":"10.1016\/j.autrev.2019.05.006_bb0790","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.tox.2016.11.018","article-title":"Non-linear dose-response of aluminium hydroxide adjuvant particles: selective low dose neurotoxicity","volume":"375","author":"Cr\u00e9peaux","year":"2017","journal-title":"Toxicology"},{"key":"10.1016\/j.autrev.2019.05.006_bb0795","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1042\/bj2800527","article-title":"Aluminium transport in blood serum. Binding of aluminium by human transferrin in the presence of human albumin and citrate","volume":"280","author":"Fatemi","year":"1991","journal-title":"Biochem J"},{"key":"10.1016\/j.autrev.2019.05.006_bb0800","series-title":"Nanomedicine, Volume I: basic capabilities","author":"Freitas","year":"1999"},{"issue":"4","key":"10.1016\/j.autrev.2019.05.006_bb0805","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.3233\/JAD-160648","article-title":"The identification of aluminum in human brain tissue using Lumogallion and fluorescence microscopy","volume":"54","author":"Mirza","year":"2016","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.autrev.2019.05.006_bb0810","series-title":"Wintrobe's Clinical hematology","year":"1993"},{"key":"10.1016\/j.autrev.2019.05.006_bb0815","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1002\/jlb.67.2.226","article-title":"Particulate adjuvants can induce macrophage survival, DNA synthesis, and a synergistic, proliferative response to GM-CSF and CSF-1","volume":"67","author":"Hamilton","year":"2000","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.autrev.2019.05.006_bb0820","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1016\/j.vaccine.2004.07.050","article-title":"Role of aluminum-containing adjuvants in antigen internalization by dendritic cells in vitro","volume":"23","author":"Morefield","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.autrev.2019.05.006_bb0825","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.imlet.2012.11.005","article-title":"Responses to multiple injections with alum alone compared to injections with alum adsorbed to proteins in mice","volume":"149","author":"Wang","year":"2012","journal-title":"Immunol Lett"},{"issue":"Suppl. 4","key":"10.1016\/j.autrev.2019.05.006_bb0830","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/10408444.2014.934439","article-title":"Systematic review of potential health risks posed by pharmaceutical, occupational and consumer exposures to metallic and nanoscale aluminum, aluminum oxides, aluminum hydroxide and its soluble salts","volume":"44","author":"Willhite","year":"2014","journal-title":"Crit Rev Toxicol"},{"key":"10.1016\/j.autrev.2019.05.006_bb0835","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1385\/NMM:9:1:83","article-title":"Aluminum adjuvant linked to Gulf War illness induces motor neuron death in mice","volume":"9","author":"Petrik","year":"2007","journal-title":"Neuromolecular Med"},{"key":"10.1016\/j.autrev.2019.05.006_bb0840","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1016\/j.jinorgbio.2009.05.019","article-title":"Aluminum hydroxide injections lead to motor deficits and motor neuron degeneration","volume":"103","author":"Shaw","year":"2009","journal-title":"J Inorg Biochem"},{"key":"10.1016\/j.autrev.2019.05.006_bb0845","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.jinorgbio.2013.07.022","article-title":"Administration of aluminium to neonatal mice in vaccine-relevant amounts is associated with adverse long term neurological outcomes","volume":"128","author":"Shaw","year":"2013","journal-title":"J Inorg Biochem"},{"key":"10.1016\/j.autrev.2019.05.006_bb0850","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.jinorgbio.2017.11.012","article-title":"Is exposure to aluminium adjuvants associated with social impairments in mice? A pilot study","volume":"181","author":"Sheth","year":"2018","journal-title":"J Inorg Biochem"},{"issue":"1","key":"10.1016\/j.autrev.2019.05.006_bb0855","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1007\/s12026-016-8826-6","article-title":"Behavioral abnormalities in female mice following administration of aluminum adjuvants and the huma papillomavirus (HPV) vaccine Gardasil","volume":"65","author":"Inbar","year":"2017","journal-title":"Immunol Res"},{"issue":"1","key":"10.1016\/j.autrev.2019.05.006_bb0860","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s12026-016-8818-6","article-title":"Phospholipid supplementation can attenuate vaccine-induced depressive-like behavior in mice","volume":"65","author":"Kivity","year":"2017","journal-title":"Immunol Res"},{"issue":"2-3","key":"10.1016\/j.autrev.2019.05.006_bb0865","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s12026-013-8404-0","article-title":"Autoimmune\/autoinflammatory syndrome induced by adjuvants (ASIA syndrome) in commercial sheep","volume":"56","author":"Lujan","year":"2013","journal-title":"Immunol Res"},{"issue":"24","key":"10.1016\/j.autrev.2019.05.006_bb0870","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1136\/vr.b4849","article-title":"Possible adverse reactions in sheep after vaccination with inactivated BTV vaccines","volume":"166","author":"Gonz\u00e1lez","year":"2010","journal-title":"Vet Rec"},{"key":"10.1016\/j.autrev.2019.05.006_bb0875","doi-asserted-by":"crossref","first-page":"2406","DOI":"10.3389\/fimmu.2018.02406","article-title":"Molecular Signature of Aluminum Hydroxide Adjuvant in Ovine PBMCs by Integrated mRNA and microRNA Transcriptome Sequencing","volume":"9","author":"Varela-Mart\u00ednez","year":"2018","journal-title":"Front Immunol."},{"issue":"8769","key":"10.1016\/j.autrev.2019.05.006_bb0880","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/0140-6736(91)91440-6","article-title":"Chronic fatigue syndrome: clinical condition associated with immune activation","volume":"338","author":"Landay","year":"1991","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.autrev.2019.05.006_bb0885","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.1400121","article-title":"Distinct plasma immune signatures in ME\/CFS are present early in the course of illness","volume":"1","author":"Hornig","year":"2015","journal-title":"Sci Adv"},{"issue":"7","key":"10.1016\/j.autrev.2019.05.006_bb0890","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1523\/JNEUROSCI.3567-08.2009","article-title":"Cerebral microglia recruit monocytes into the brain in response to tumor necrosis factor alpha signaling during peripheral organ inflammation","volume":"29","author":"D'Mello","year":"2009","journal-title":"J Neurosci"},{"key":"10.1016\/j.autrev.2019.05.006_bb0895","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.bbi.2013.10.009","article-title":"Liver-brain interactions in inflammatory liver diseases: implications for fatigue and mood disorders","volume":"35","author":"D'Mello","year":"2014","journal-title":"Brain Behav Immun"},{"issue":"8","key":"10.1016\/j.autrev.2019.05.006_bb0900","doi-asserted-by":"crossref","first-page":"5402","DOI":"10.4049\/jimmunol.180.8.5402","article-title":"The adjuvants aluminum hydroxide and MF59 induce monocyte and granulocyte chemoattractants and enhance monocyte differentiation toward dendritic cells","volume":"180","author":"Seubert","year":"2008","journal-title":"J Immunol"},{"issue":"6776","key":"10.1016\/j.autrev.2019.05.006_bb0905","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/35006097","article-title":"Control of TH2 polarization by the chemokine monocyte chemoattractant protein-1","volume":"404","author":"Gu","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.autrev.2019.05.006_bb0910","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1038\/ni.1631","article-title":"Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilization","volume":"9","author":"Hornung","year":"2008","journal-title":"Nat Immunol"},{"key":"10.1016\/j.autrev.2019.05.006_bb0915","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.neuroscience.2017.06.048","article-title":"NLRP3 inflammasome activation mediates fatigue-like behaviors in mice via neuroinflammation","volume":"358","author":"Zhang","year":"2017","journal-title":"Neuroscience"},{"issue":"2","key":"10.1016\/j.autrev.2019.05.006_bb0920","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1111\/j.1460-9568.2004.03514.x","article-title":"Complete Freunds adjuvant-induced peripheral inflammation evokes glial activation and proinflammatory cytokine expression in the CNS","volume":"20","author":"Raghavendra","year":"2004","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.autrev.2019.05.006_bb0925","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.neulet.2009.03.079","article-title":"Chronic brain inflammation impairs two forms of long-term potentiation in the rat hippocampal CA1 area","volume":"456","author":"Min","year":"2009","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.autrev.2019.05.006_bb0930","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jneuroim.2015.08.019","article-title":"Neonatal vaccination with bacillus Calmette\u2013Gu\u00e9rin and hepatitis B vaccines modulates hippocampal synaptic plasticity in rats","volume":"vol. 288","author":"Li","year":"2015","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.autrev.2019.05.006_bb0935","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/S0091-6749(99)70503-8","article-title":"Estrogen enhances immunoglobulin production by human PBMCs","volume":"103","author":"Kanda","year":"1999","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.autrev.2019.05.006_bb0940","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1086\/317537","article-title":"Type 1\/Type 2 Immunity in infectious diseases","volume":"32","author":"Spellberg","year":"2001","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.autrev.2019.05.006_bb0945","first-page":"1237","article-title":"Academic stress-induced changes in Th1- and Th2-cytokine responseSaudi","volume":"25","author":"Assaf","year":"2017","journal-title":"Pharm J"},{"key":"10.1016\/j.autrev.2019.05.006_bb0950","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1016\/S0140-6736(97)01164-1","article-title":"Gulf War syndrome: is it due to a systemic shift in cytokine balance towards a Th2 profile?","volume":"349","author":"Rook","year":"1997","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.autrev.2019.05.006_bb0955","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/mp.2015.29","article-title":"Cytokine network analysis of cerebrospinal fluid in myalgic encephalomyelitis\/chronic fatigue syndrome","volume":"21","author":"Hornig","year":"2016","journal-title":"Mol Psychiatry"},{"issue":"7701","key":"10.1016\/j.autrev.2019.05.006_bb0960","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1038\/s41586-018-0023-4","article-title":"Innate immune memory in the brain shapes neurological disease hallmarks","volume":"556","author":"Wendeln","year":"2018","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.autrev.2019.05.006_bb0965","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1189\/jlb.5RI0315-096R","article-title":"Trained innate immunity as underlying mechanism for the long-term, nonspecific effects of vaccines","volume":"98","author":"Blok","year":"2015","journal-title":"J Leukoc Biol"},{"issue":"10","key":"10.1016\/j.autrev.2019.05.006_bb0970","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1004485","article-title":"Autophagy controls BCG-induced trained immunity and the response to intravesical BCG therapy for bladder cancer","volume":"10","author":"Buffen","year":"2014","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.autrev.2019.05.006_bb0975","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1002\/glia.22350","article-title":"Microglia and neurodegeneration: the role of systemic inflammation","volume":"61","author":"Cunningham","year":"2013","journal-title":"Glia"},{"key":"10.1016\/j.autrev.2019.05.006_bb0980","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2018.00298","article-title":"The potential role of trained immunity in autoimmune and autoinflammatory disorders","volume":"9","author":"Arts","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.autrev.2019.05.006_bb0985","doi-asserted-by":"crossref","DOI":"10.3389\/fped.2018.00373","article-title":"Myalgic Encephalomyelitis\/Chronic Fatigue Syndrome in the era of the human microbiome: persistent pathogens drive chronic symptoms by interfering with host metabolism, gene expression, and immunity","volume":"6","author":"Proal","year":"2018","journal-title":"Front Pediatr"},{"key":"10.1016\/j.autrev.2019.05.006_bb0990","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.coi.2014.05.006","article-title":"Autophagy and the immune function in aging","volume":"29","author":"Cuervo","year":"2014","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.autrev.2019.05.006_bb0995","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/j.1462-5822.2009.01381.x","article-title":"Crohn's disease-associated adherent-invasive E. coli are selectively favoured by impaired autophagy to replicate intracellularly","volume":"12","author":"Lapaquette","year":"2010","journal-title":"Cell Microbiol"},{"issue":"3","key":"10.1016\/j.autrev.2019.05.006_bb1000","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1038\/ng.762","article-title":"A synonymous variant in IRGM alters a binding site for miR-196 and causes deregulation of IRGM-dependent xenophagy in Crohn's disease","volume":"43","author":"Brest","year":"2011","journal-title":"Nat Genet"},{"key":"10.1016\/j.autrev.2019.05.006_bb1005","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1146\/annurev-physiol-030212-183658","article-title":"Autophagy and intestinal homeostasis","volume":"75","author":"Patel","year":"2013","journal-title":"Annu Rev Physiol"},{"issue":"10","key":"10.1016\/j.autrev.2019.05.006_bb1010","first-page":"2286","article-title":"Macrophagic myofasciitis: improvement with antibiotic therapy","volume":"26","author":"Ch\u00e9rin","year":"1999","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2019.05.006_bb1015","author":"ANSM"},{"issue":"2","key":"10.1016\/j.autrev.2019.05.006_bb1020","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1177\/0961203311430090","article-title":"Aluminum as an adjuvant in Crohn's disease induction","volume":"21","author":"Lerner","year":"2012","journal-title":"Lupus"},{"issue":"1","key":"10.1016\/j.autrev.2019.05.006_bb1025","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.jcmgh.2018.09.012","article-title":"Aluminum ingestion promotes colorectal hypersensitivity in rodents","volume":"7","author":"Esquerre","year":"2018","journal-title":"Cell Mol Gastroenterol Hepatol"},{"issue":"13","key":"10.1016\/j.autrev.2019.05.006_bb1030","doi-asserted-by":"crossref","first-page":"E2960","DOI":"10.1073\/pnas.1720696115","article-title":"Chronic stress promotes colitis by disturbing the gut microbiota and triggering immune system response","volume":"115","author":"Gao","year":"2018","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"10.1016\/j.autrev.2019.05.006_bb1035","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.immuni.2014.08.009","article-title":"TLR5-mediated sensing of gut microbiota is necessary for antibody responses to seasonal influenza vaccination","volume":"41","author":"Oh","year":"2014","journal-title":"Immunity"},{"issue":"2","key":"10.1016\/j.autrev.2019.05.006_bb1040","first-page":"11","article-title":"Do gut microbiota mediate adverse vaccine reaction?","volume":"2","author":"Yuan","year":"2018","journal-title":"Ann Clin Trials Vaccines Res"},{"key":"10.1016\/j.autrev.2019.05.006_bb1045","first-page":"9","article-title":"Hypergammaglobulinemia by prolonged adjuvanticity in man disorders developed after augmentation mammoplasty","volume":"2122","author":"Miyoshi","year":"1964","journal-title":"Jpn Med J"},{"issue":"2","key":"10.1016\/j.autrev.2019.05.006_bb1050","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1111\/j.1365-2362.2010.02389.x","article-title":"Silicone and autoimmunity","volume":"41","author":"Hajdu","year":"2011","journal-title":"Eur J Clin Invest"},{"issue":"1","key":"10.1016\/j.autrev.2019.05.006_bb1055","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1007\/s12026-016-8821-y","article-title":"Two hundreds cases of ASIA syndrome following silicone implants: a comparative study of 30 years and a review of current literature","volume":"65","author":"Colaris","year":"2017","journal-title":"Immunol Res"},{"key":"10.1016\/j.autrev.2019.05.006_bb1060","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.jaut.2014.03.003","article-title":"Sj\u00f6gren's syndrome: another facet of the autoimmune\/inflammatory syndrome induced by adjuvants (ASIA)","volume":"51","author":"Colafrancesco","year":"2014","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2019.05.006_bb1065","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.phrs.2014.10.005","article-title":"Is narcolepsy a classical autoimmune disease?","volume":"92","author":"Arango","year":"2015","journal-title":"Pharmacol Res"},{"issue":"7","key":"10.1016\/j.autrev.2019.05.006_bb1070","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1177\/0961203316686406","article-title":"Autoimmune\/inflammatory syndrome induced by adjuvants (Shoenfeld's syndrome) - an update","volume":"26","author":"Watad","year":"2017","journal-title":"Lupus"},{"issue":"4","key":"10.1016\/j.autrev.2019.05.006_bb1075","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1111\/aji.12151","article-title":"Human papilloma virus vaccine and primary ovarian failure: another facet of the autoimmune\/inflammatory syndrome induced by adjuvants","volume":"70","author":"Colafrancesco","year":"2013","journal-title":"Am J Reprod Immunol"},{"issue":"1\u20132","key":"10.1016\/j.autrev.2019.05.006_bb1080","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s12026-014-8622-0","article-title":"Adjuvants and lymphoma risk as part of the ASIA spectrum","volume":"61","author":"Butnaru","year":"2015","journal-title":"Immunol Res"},{"key":"10.1016\/j.autrev.2019.05.006_bb1085","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s11011-013-9435-x","article-title":"Mitochondrial dysfunctions in myalgic encephalomyelitis\/chronic fatigue syndrome explained by activated immuno-inflammatory, oxidative and nitrosative stress pathways","volume":"29","author":"Morris","year":"2014","journal-title":"Metab Brain Dis"},{"issue":"6","key":"10.1016\/j.autrev.2019.05.006_bb1090","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.autrev.2018.01.009","article-title":"European network on ME\/CFS (EUROMENE). Myalgic Encephalomyelitis\/Chronic Fatigue Syndrome - Evidence for an autoimmune disease","volume":"17","author":"Sotzny","year":"2018","journal-title":"Autoimmun Rev"},{"issue":"1","key":"10.1016\/j.autrev.2019.05.006_bb1095","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1007\/s12026-017-8912-4","article-title":"Are the autoimmune\/inflammatory syndrome induced by adjuvants (ASIA) and the undifferentiated connective tissue disease (UCTD) related to each other? A case-control study of environmental exposures","volume":"65","author":"Scanzi","year":"2017","journal-title":"Immunol Res"},{"issue":"3","key":"10.1016\/j.autrev.2019.05.006_bb1100","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0193672","article-title":"Immunoadsorption to remove \u00df2 adrenergic receptor antibodies in Chronic Fatigue Syndrome CFS\/ME","volume":"13","author":"Scheibenbogen","year":"2018","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.autrev.2019.05.006_bb1105","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0129898","article-title":"B-Lymphocyte depletion in Myalgic Encephalopathy\/Chronic Fatigue Syndrome. An Open-Label Phase II Study with Rituximab maintenance treatment","volume":"10","author":"Fluge","year":"2015","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.autrev.2019.05.006_bb1110","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1007\/s12026-016-8855-1","article-title":"Postural tachycardia syndrome (POTS) with anti-NMDA receptor antibodies after human papillomavirus vaccination","volume":"65","author":"Blitshteyn","year":"2017","journal-title":"Immunol Res"},{"issue":"1","key":"10.1016\/j.autrev.2019.05.006_bb1115","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1007\/s12026-016-8811-0","article-title":"Severe manifestations of autoimmune syndrome induced by adjuvants (Shoenfeld's syndrome)","volume":"65","author":"Jara","year":"2017","journal-title":"Immunol Res"},{"issue":"5","key":"10.1016\/j.autrev.2019.05.006_bb1120","first-page":"707","article-title":"Valacyclovir treatment in Epstein-Barr virus subset chronic fatigue syndrome: thirty-six months follow-up","volume":"21","author":"Lerner","year":"2007","journal-title":"In Vivo"},{"issue":"11","key":"10.1016\/j.autrev.2019.05.006_bb1125","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1093\/qjmed\/hcq113","article-title":"Long-term persistence after acute Q fever of non-infective Coxiella burnetii cell components, including antigens","volume":"103","author":"Sukocheva","year":"2010","journal-title":"QJM"},{"issue":"2","key":"10.1016\/j.autrev.2019.05.006_bb1130","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1136\/jcp.2009.070466","article-title":"Acute enterovirus infection followed by myalgic encephalomyelitis\/chronic fatigue syndrome (ME\/CFS) and viral persistence","volume":"63","author":"Chia","year":"2010","journal-title":"J Clin Pathol"},{"issue":"2","key":"10.1016\/j.autrev.2019.05.006_bb1135","article-title":"Persistent borrelia infection in patients with ongoing symptoms of lyme disease","volume":"6","author":"Middelveen","year":"2018","journal-title":"Healthc (Basel)"},{"issue":"4","key":"10.1016\/j.autrev.2019.05.006_bb1140","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.autrev.2008.08.003","article-title":"Immunological aspects of chronic fatigue syndrome","volume":"8","author":"Lorusso","year":"2009","journal-title":"Autoimmun Rev"},{"issue":"1","key":"10.1016\/j.autrev.2019.05.006_bb1145","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/nrendo.2011.153","article-title":"Hypothalamic-pituitary-adrenal axis dysfunction in chronic fatigue syndrome","volume":"8","author":"Papadopoulos","year":"2012","journal-title":"Nat Rev Endocrinol"},{"issue":"1","key":"10.1016\/j.autrev.2019.05.006_bb1150","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1751-0759-7-5","article-title":"Helland IB Relationship between autonomic cardiovascular control, case definition, clinical symptoms, and functional disability in adolescent chronic fatigue syndrome: an exploratory study","volume":"7","author":"Wyller","year":"2013","journal-title":"Biopsychosoc Med"},{"issue":"21","key":"10.1016\/j.autrev.2019.05.006_bb1155","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.89376","article-title":"Metabolic profiling indicates impaired pyruvate dehydrogenase function in myalgic encephalopathy\/chronic fatigue syndrome","volume":"1","author":"Fluge","year":"2016","journal-title":"JCI Insight"},{"issue":"9","key":"10.1016\/j.autrev.2019.05.006_bb1160","doi-asserted-by":"crossref","first-page":"6806","DOI":"10.1007\/s12035-016-0170-2","article-title":"Hypothalamic-Pituitary-Adrenal Hypofunction in Myalgic Encephalomyelitis (ME)\/Chronic Fatigue Syndrome (CFS) as a Consequence of Activated Immune-Inflammatory and Oxidative and Nitrosative Pathways","volume":"54","author":"Morris","year":"2017","journal-title":"Mol Neurobiol"},{"issue":"37","key":"10.1016\/j.autrev.2019.05.006_bb1165","doi-asserted-by":"crossref","first-page":"E5472","DOI":"10.1073\/pnas.1607571113","article-title":"Metabolic features of chronic fatigue syndrome","volume":"113","author":"Naviaux","year":"2016","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"29","key":"10.1016\/j.autrev.2019.05.006_bb1170","first-page":"269","article-title":"Global Advisory Committee on Vaccine Safety","volume":"79","author":"WHO","year":"2004","journal-title":"Wkly Epidemiol Rec"},{"issue":"48","key":"10.1016\/j.autrev.2019.05.006_bb1175","doi-asserted-by":"crossref","first-page":"6736","DOI":"10.1016\/j.vaccine.2015.10.076","article-title":"Cumulative and episodic vaccine aluminum exposure in a population-based cohort of young children","volume":"33","author":"Glanz","year":"2015","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.autrev.2019.05.006_bb1180","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1080\/14760584.2017.1244484","article-title":"Calcium phosphate: a substitute for aluminum adjuvants?","volume":"16","author":"Masson","year":"2017","journal-title":"Expert Rev Vaccines"},{"issue":"1","key":"10.1016\/j.autrev.2019.05.006_bb1185","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1080\/14760584.2016.1213632","article-title":"Adjuvant system AS01: helping to overcome the challenges of modern vaccines","volume":"16","author":"Didierlaurent","year":"2017","journal-title":"Expert Rev Vaccines"},{"issue":"1","key":"10.1016\/j.autrev.2019.05.006_bb1190","first-page":"74","article-title":"Microcrystalline Tyrosine: an apporiate alternative to aluminium as adjuvant in vaccines and allergen immunotherapy","volume":"3","author":"Leuthard","year":"2018","journal-title":"EMJ Allergy Immunol"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997219301090?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997219301090?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T21:14:57Z","timestamp":1761599697000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568997219301090"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7]]},"references-count":238,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2019,7]]}},"alternative-id":["S1568997219301090"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2019.05.006","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2019,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Myalgia and chronic fatigue syndrome following immunization: macrophagic myofasciitis and animal studies support linkage to aluminum adjuvant persistency and diffusion in the immune system","name":"articletitle","label":"Article Title"},{"value":"Autoimmunity Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.autrev.2019.05.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}